2.0 b25a6d26-7db0-4005-9769-3ebb27a7e24e *AOS_Breast_R APBI 30Gy 5fx v1 Thorax Breast Right *AOS_Breast_R APBI 30Gy 5fx AOS sample template - to be copied, reviewed, modified as deemed appropriate, and approved by site physicist Summary: 5fx right breast APBI References: "Leveraging Intelligent Optimization for Automated, Cardiac-Sparing Accelerated Partial Breast Treatment Planning". J. Pogue et. al, Frontiers in Oncology, 2023. "Improved Dosimetry and Plan Quality for Accelerated Partial Breast Irradiation Using Online Adaptive Radiation Therapy: A Single Institutional Study". J. Pogue et. al, Advances in Rad Onc, 2024. Version 1.4 Created: 2/18/25 (SEG) - left breast Last updated: 2/23/25 (PHH) - modifications for right breast 4/18/25 (PHH) - Corrected OAR label (SpinalCanal) ********************************************************************* Rx: 30 Gy in 5 fractions, PTV 30Gy >= 95% Margins: "An isotropic 1cm gross tumor volume (GTV) expansion was utilized for clinical target volume (CTV) generation... an isotropic 3mm CTV expansion was utilized for PTV generation... PTV_Eval volumes were created by carving out the PTV at anatomical boundaries (i.e., lung, rib, chest wall, and 5mm from the skin)." - Pogue et. al - Frontiers * using PTV_Eval minus skin rather than additional 5mm from skin per Pogue et. al - Advances Planning Structures: The template contains three rings constituting seven objectives focused solely on conformity, fall-off, and limiting high dose spillage. The inner, middle, and outer rings are derived from (0 - 0.5)cm, (0.5 - 1.0)cm, and (1.0 – 3.0)cm PTV_Eval expansions inside of the Body, respectively." - Pogue et. al OAR Constraints: See Pogue et. al Structures have been named according to TG 263. 5018 FMA 3.2 Bones 4290904001 Bones 7088 FMA 3.2 Heart 4294954751 Heart 7309 FMA 3.2 Lung right 4278190335 Lung_R 7310 FMA 3.2 Lung left 4294967040 Lung_L 9680 FMA 3.2 Spinal canal 4286644223 SpinalCanal 68877 FMA 3.2 Both lungs 4294934528 Lungs 321496 FMA 3.2 Breast right 4289485311 Breast_R 321497 FMA 3.2 Breast left 4294926079 Breast_L 7163 FMA 3.2 Skin 4286512789 Skin Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items 3 0 ]]> 264793 FMA 3.2 Set of left ribs 4279598331 Ribs_L 264792 FMA 3.2 Set of right ribs 4291231686 Ribs_R 25558 FMA 3.2 Right chest wall 4280929433 Chestwall_R R-429E0 SRT Gross tumor volume 4284678342 GTV R-429EB SRT Clinical target volume 4280918220 CTV Target1 R-429E0 SRT Gross tumor volume 10 Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> R-429EC SRT Planning target volume 4294901760 PTV Target2 R-429EB SRT Clinical target volume 3.0000000000000004 Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> R-429EC SRT Planning target volume 4294901760 PTV_eval Target3 R-429EC SRT Planning target volume OAR12 25558 FMA 3.2 Right chest wall OAR3 7309 FMA 3.2 Lung right OAR11 264792 FMA 3.2 Set of right ribs OAR9 7163 FMA 3.2 Skin Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items -5 ]]> NormalTissue 99VMS_STRUCTCODE 1.0 Unidentified structure 4289604044 Breast_R - PTV_eval OAR7 321496 FMA 3.2 Breast right Target4 R-429EC SRT Planning target volume Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> NormalTissue 99VMS_STRUCTCODE 1.0 Unidentified structure 4287954944 Ring_Inner Target4 R-429EC SRT Planning target volume 0 5 Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> NormalTissue 99VMS_STRUCTCODE 1.0 Unidentified structure 4294925147 Ring_Middle Target4 R-429EC SRT Planning target volume -5 10 Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> NormalTissue 99VMS_STRUCTCODE 1.0 Unidentified structure 4294954188 Ring_Outer Target4 R-429EC SRT Planning target volume -10 30 Body BODY 99VMS_STRUCTCODE 1.0 Body plus other external items ]]> Target3 6 VolumeDose ShouldBeMoreOrEqual 95 Relative 100 Relative VolumeDose ShouldBeMoreOrEqual 90 Relative 100 Relative 4 1 Target4 6 ConformityIndex 1.3 true VolumeDose ShouldBeMoreOrEqual 99 Relative 28.5 Absolute VolumeDose ShouldBeMoreOrEqual 98 Relative 28.5 Absolute 2 1 VolumeDose ShouldBeMoreOrEqual 97.5 Relative 30 Absolute VolumeDose ShouldBeMoreOrEqual 95 Relative 30 Absolute 1 1 DoseVolume ShouldBeLessOrEqual 0.03 Absolute 37 Absolute DoseVolume ShouldBeLessOrEqual 0.03 Absolute 39 Absolute 2 3 Target1 6 VolumeDose ShouldBeMoreOrEqual 100 Relative 30 Absolute VolumeDose ShouldBeMoreOrEqual 99 Relative 30 Absolute 2 4 DoseVolume ShouldBeMoreOrEqual 100 Relative 30.05 Absolute DoseVolume ShouldBeMoreOrEqual 100 Relative 30 Absolute 2 5 Target2 6 VolumeDose ShouldBeMoreOrEqual 99 Relative 30 Absolute VolumeDose ShouldBeMoreOrEqual 98 Relative 30 Absolute 2 2 OAR2 VolumeDose ShouldBeLessOrEqual 3 Relative 1.5 Absolute VolumeDose ShouldBeLessOrEqual 5 Relative 1.5 Absolute 2 11 OAR2 VolumeDose ShouldBeLessOrEqual 0.5 Relative 7 Absolute VolumeDose ShouldBeLessOrEqual 10 Relative 7 Absolute 2 12 OAR2 DoseVolume ShouldBeLessOrEqual 0.03 Absolute 12 Absolute DoseVolume ShouldBeLessOrEqual 0.03 Absolute 15 Absolute 3 10 OAR3 VolumeDose ShouldBeLess 5 Relative 9 Absolute VolumeDose ShouldBeLessOrEqual 10 Relative 9 Absolute 2 7 OAR3 VolumeDose ShouldBeLessOrEqual 15 Relative 5 Absolute VolumeDose ShouldBeLessOrEqual 20 Relative 5 Absolute 2 8 OAR3 VolumeDose ShouldBeLessOrEqual 1 Relative 15 Absolute 2 9 OAR4 VolumeDose ShouldBeLess 5 Relative 1.5 Absolute VolumeDose ShouldBeLessOrEqual 10 Relative 1.5 Absolute 2 10 OAR8 VolumeDose ShouldBeLess 15 Relative 5 Absolute VolumeDose ShouldBeLessOrEqual 20 Relative 5 Absolute 3 9 OAR8 VolumeDose ShouldBeLess 0.03 Absolute 15 Absolute 3 8 OAR9 DoseVolume ShouldBeLess 0.03 Absolute 37.5 Absolute 3 12 OAR9 VolumeDose ShouldBeLessOrEqual 8 Absolute 36.5 Absolute VolumeDose ShouldBeLessOrEqual 10 Absolute 36.5 Absolute 3 11 ControlRegion1 VolumeDose ShouldBeLessOrEqual 5 Relative 20 Absolute VolumeDose ShouldBeLessOrEqual 30 Relative 20 Absolute 2 13 ControlRegion1 VolumeDose ShouldBeLessOrEqual 2 Relative 30 Absolute VolumeDose ShouldBeLessOrEqual 20 Relative 30 Absolute 2 14 ControlRegion1 VolumeDose ShouldBeLessOrEqual 15 Relative 15 Absolute VolumeDose ShouldBeLessOrEqual 40 Relative 15 Absolute 2 15 ControlRegion2 DoseVolume ShouldBeLessOrEqual 0.03 Absolute 30 Absolute 3 5 ControlRegion2 VolumeDose ShouldBeLessOrEqual 6 Relative 30 Absolute VolumeDose ShouldBeLessOrEqual 8 Relative 30 Absolute 3 6 ControlRegion2 MeanDose ShouldBeLessOrEqual 20 Absolute MeanDose ShouldBeLessOrEqual 22 Absolute 3 7 ControlRegion3 MeanDose ShouldBeLessOrEqual 11.5 Absolute MeanDose ShouldBeLessOrEqual 20 Absolute 3 4 ControlRegion3 DoseVolume ShouldBeLessOrEqual 0.03 Absolute 20 Absolute DoseVolume ShouldBeLessOrEqual 0.03 Absolute 21 Absolute 3 3 ControlRegion4 DoseVolume ShouldBeLessOrEqual 0.03 Absolute 14 Absolute DoseVolume ShouldBeLessOrEqual 0.03 Absolute 15 Absolute 3 1 ControlRegion4 MeanDose ShouldBeLessOrEqual 4.5 Absolute MeanDose ShouldBeLessOrEqual 14 Absolute 3 2 OAR11 VolumeDose ShouldBeLessOrEqual 0.8 Absolute 30 Absolute VolumeDose ShouldBeLessOrEqual 1 Absolute 30 Absolute 2 6 NoNormalization 1 None 1 None 1 None 1 None 1 None